(b)(4).A manufacturing record evaluation was performed for the finished device batch qebchl and no non-conformances were identified.To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Attempts are being made to receive additional information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure? product lot number? on what tissue was the suture used? what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? were there any pre-existing signs/symptoms of active inflammation/infection prior to this surgical procedure? please specify.Did the patient receive any prophylactic antibiotics pre-, intra- or post-operation? if yes, please specify.What medication was given to treat the infection? please specify.Did the operating surgeon observe any suture deficiency or anomaly before, during or after the suture placement? please specify.Other relevant patient history/comorbidities/concomitant medications? what is physicians opinion as to the etiology of or contributing factors to this event (bacterial infection)? what is the patients current status? if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
It was reported that the patient underwent a cervical cerclage procedure on (b)(6) 2021 and the suture tape was used.Post-op, the patient experienced post-op infection.On (b)(6) 2021, the cervical secretion was found to contain escherichia coli + and the patient was isolated by single contact.After antibiotic treatment, the vaginal secretion was negative for bacterial culture on (b)(6) 2021.Additional information has been requested.
|